SG

Samar Ghosh

Active Director Director DIN 08672842
DIN 08672842 First appointment Jan 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Samar Ghosh

Data last updated:

Samar Ghosh is a Director at Sensuous Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Sensuous Pharmaceuticals Private Limited reported revenue of ₹75 Lakh (FY 2024).

DIN 08672842
Primary Designation Director
Industry Pharma
First Appointment 20 Jan 2020
Oldest Company Age 6 yrs
Largest company Sensuous Pharmaceuticals Private Limited · ₹75 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jan 20202020₹75 Lakh (FY 2024)Active

Board colleagues of Samar Ghosh

NameDINCompanyDesignation
Sumita Das09186247Sensuous Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sensuous Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Samar Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samar Ghosh

Samar Ghosh currently holds 1 directorship: Sensuous Pharmaceuticals Private Limited (Director, since 20 Jan 2020, revenue ₹75 Lakh (FY 2024)).

Samar Ghosh was first appointed on 20 Jan 2020 as Director at Sensuous Pharmaceuticals Private Limited.

The current boards of Samar Ghosh's companies include Sumita Das (Sensuous Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available